{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-064735","form_type":"8-K","ticker":"SILO","cik":"0001514183","company_name":"Silo Pharma, Inc.","filed_at":"2022-10-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.933940+00:00","generated_at":"2026-06-23T02:57:14.387557+00:00","sec_items":["1.01","5.02","7.01","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Silo Pharma hires Eric Weisblum as CEO with $350K salary, extends Columbia research pact","bullets":["Eric Weisblum appointed CEO; base salary $350K/yr, signing bonus $100K, annual bonus up to $350K.","Severance includes 24 months base salary, COBRA coverage, and prorated bonus on termination without cause or change in control.","Columbia University agreement extended; option to license SPC-14 (Alzheimer's) and SPC-15 (stress-induced anxiety).","CFO Daniel Ryweck salary increased to $60K/yr per amendment dated October 12, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-064735","json":"https://secwatch.observer/filing/0001213900-22-064735.json","markdown":"https://secwatch.observer/filing/0001213900-22-064735.md","text":"https://secwatch.observer/filing/0001213900-22-064735.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1514183/000121390022064735/0001213900-22-064735-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1514183/000121390022064735/ea167262-8k_silopharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T02:57:14.387557+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7cad61fc67","claim":"Eric Weisblum was appointed as Chief Executive Officer at Silo Pharma, Inc..","evidence_excerpt":"On October 12, 2022, the Company entered into an employment agreement with Eric Weisblum (the “Weisblum Employment Agreement”)","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1514183/000121390022064735/0001213900-22-064735-index.htm","confidence":0.7,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}